DexCom Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.DexCom Inc. (DXCM) shares rose 2.56% to $73.37, outperforming competitors Abbott Laboratories and Insulet Corp. on a strong trading day. This marks the second consecutive day of gains for DexCom, though it remains 18.46% below its 52-week high. The broader market also saw gains, with the S&P 500 up 0.02% and the Dow Jones Industrial Average up 0.51%. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) rallied 2.56% to $73.37 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.
This was the stock's second consecutive day of gains.
DexCom Inc. closed 18.46% below its 52-week high of $89.98, which the company reached on July 30th.
The stock outperformed some of its competitors Monday, as Abbott Laboratories (ABT) rose 1.39% to $104.49 and Insulet Corp. (PODD) rose 1.07% to $165.00.
Trading volume (5.0 M) remained 676,974 below its 50-day average volume of 5.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-27-26 1700ET